The Enterprise Value as of December 2025 (TTM) for Rekah Pharmaceutical Industry Ltd. (REKA.TA) is 265.21M

According to Rekah Pharmaceutical Industry Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 265.21M. This represents a change of -6.23% compared to the average of 282.82M of the last 4 quarters.

Rekah Pharmaceutical Industry Ltd. (REKA.TA) Historical Enterprise Value (quarterly & annually)

How has REKA.TA Enterprise Value performed in the past?

The mean historical Enterprise Value of Rekah Pharmaceutical Industry Ltd. over the last ten years is 333.02M. The current 265.21M Enterprise Value has changed 7.86% with respect to the historical average. Over the past ten years (40 quarters), REKA.TA's Enterprise Value was at its highest in in the June 2018 quarter at 482.51M. The Enterprise Value was at its lowest in in the June 2016 quarter at 225.66M.

Rekah Pharmaceutical Industry Ltd. (REKA.TA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Rekah Pharmaceutical Industry Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Rekah Pharmaceutical Industry Ltd. (REKA.TA) Average Enterprise Value

How has REKA.TA Enterprise Value performed in the past?

The current Enterprise Value of Rekah Pharmaceutical Industry Ltd. (REKA.TA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Rekah Pharmaceutical Industry Ltd. (REKA.TA) Enterprise Value vs. Peers

How is REKA.TA’s Enterprise Value compared to its peers?

Rekah Pharmaceutical Industry Ltd.’s Enterprise Value is less than G.F.C Green Fields Capital Ltd. (685.21M), greater than Kadimastem Ltd (133.31M), greater than Seach Medical Group Ltd (101.02M), greater than Together Pharma Ltd (99.29M), greater than Pluri Inc. (46.33M), greater than Nissan Medical Industries Ltd (260.18M), greater than Tikun Olam-Cannbit Pharmaceuticals Ltd (43.73M), greater than Geffen Residence & Renewal Ltd (225.08M), greater than Dna Group (T.R.) Ltd (65.40M), greater than Enlivex Therapeutics Ltd. (25.91M),

Build a custom stock screener for Rekah Pharmaceutical Industry Ltd. (REKA.TA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rekah Pharmaceutical Industry Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Rekah Pharmaceutical Industry Ltd. (REKA.TA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Rekah Pharmaceutical Industry Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.